(Q35198056)

7 August 2017

1 reference

title

Clinical pharmacology and neuroprotection in Parkinson's disease (English)

1 reference

7 August 2017

Masahiro Nomoto

1

1 reference

7 August 2017

language of work or name

1 reference

1 August 2003

1 reference

Parkinsonism and Related Disorders

7 August 2017

published in

1 reference

7 August 2017

volume

9 Suppl 2

1 reference

7 August 2017

page(s)

S55-8

1 reference

Increased risk of Parkinson's disease in parents and siblings of patients

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Risk of Parkinson's disease among first-degree relatives: A community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Association between the oxidative polymorphism and early onset of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

1 reference

7 January 2021

Glutathione transferases--structure and catalytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Parkinson disease in twins: an etiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

The metabolic rate and vulnerability of dopaminergic neurons, and adenosine dynamics in the cerebral cortex, nucleus accumbens, caudate nucleus, and putamen of the common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Lipopolysaccharide prevents cell death caused by glutathione depletion: possible mechanisms of protection

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Glucose protection from MPP+-induced apoptosis depends on mitochondrial membrane potential and ATP synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900044-0

7 January 2021

10.1016/S1353-8020(03)00044-0

Identifiers

DOI

1 reference

7 August 2017

1 reference